Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency

- Growth Hormone Deficiency
- Terminated

Study Title: Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD)

Teva Identifier: TV1106-IMM-30022 | 2014-002736-13

ClinicalTrials.gov Identifier: NCT02410356

Study Status: Terminated

Trial Condition(s): Growth Hormone Deficiency

Interventions: Drug: TV-1106 | Drug: dGH

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years and older

Trial Duration: April 30, 2015 - April 30, 2016

Phase: Phase 3

Study Type

Interventional